Real-time enrollment status for this inflammatory myopathies clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 1:18 AM UTC
| NCT Number | NCT06455449 |
| Recruiting Status | Recruiting |
| Condition | Inflammatory Myopathies |
| Phase | PHASE3 |
| Target Enrollment | 240 participants |
| Active Locations | 43 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | May 28, 2026 (May 28, 2026) |
As of July 20, 2026: Clinical trial NCT06455449 is currently recruiting participants. This phase3 study for inflammatory myopathies is actively seeking new participants at 43 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06455449 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06455449 was last updated May 28, 2026 (May 28, 2026). HelloStudys verifies this status automatically.